Stress Urinary Incontinence in Elite Athletes
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03938779 |
|
Recruitment Status : Unknown
Verified July 2019 by Telma Pires, University of Trás-os-Montes and Alto Douro.
Recruitment status was: Recruiting
First Posted : May 6, 2019
Last Update Posted : July 8, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pelvic Floor Disorders | Behavioral: Pelvic Floor Muscle Training (PFMT) Diagnostic Test: Pad test | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 15 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Intervention Model Description: | Volleyball team will be evaluated in two moments, at the beginning and 4 months after the PFMT. After 4 months, to compare with the control group and to evaluate if there are differences between groups, namely muscle strength |
| Masking: | Single (Participant) |
| Masking Description: | The participants do not know that there is a control group and an intervention group |
| Primary Purpose: | Treatment |
| Official Title: | Pelvic Floor Muscle Training and Stress Urinary Incontinence in Elite Athletes . Clinical Trial |
| Actual Study Start Date : | April 25, 2019 |
| Actual Primary Completion Date : | April 25, 2019 |
| Estimated Study Completion Date : | August 4, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Pelvic Floor Muscle Training (PFMT)
Experimental group will perform for 4 months a PFMT
|
Behavioral: Pelvic Floor Muscle Training (PFMT)
PFMT is a protocol of exercises for prevention and treatment for Stress Urinary Incontinence in elite females athletes, volleyball team |
|
Experimental: Pad test
The experimental and control group will perform the pad test twice. At the beginning of the evaluation and 4 months after the PFMT. The modified pad test, has the durability of a workout (2h30min)
|
Diagnostic Test: Pad test
Pad test is a standardised test for quantifying urine loss. Pad test is not invasive and provide an easy, inexpensive and objective assessment of urine loss. |
|
No Intervention: Kings Health Questionnaire
Kings Health Questionnaire to assess the impact of urinary incontinence on quality of life of women. Both groups will complete the questionnaire.
|
|
|
No Intervention: perineometer
Both groups will perform perineometry at baseline and 4 months after
|
- Pad-test (Short-term) [ Time Frame: 2 hour 30 min ]The pad test is a standardised test for quantifying urine loss.
- Kings Health Questionnaire (KHQ) [ Time Frame: 10 minutes ]Was constructed in order to assess the impact of urinary incontinence on quality of life women, also evaluating urinary symptoms and subjective measures of severity. The KHQ is composed of 21 items investigating nine domains and it evaluates the agreement of the subjects on a 4- and 5- option Likert scale: general health perceptions (1item), incontinence impact (1 item), role limitations (2 items), physical limitations (2 items), social limitations (2 items), personal relationships (3 items), emotions (3 items), sleep and energy (2 items) and severity measures (5 items). Additionally, it has an independent subscale designed as a Symptom Severity Scale, which contains 11 items, measuring the presence and severity of urinary symptoms (Appendix 5). The KHQ scored from a minimum of 0 (best QoL) to a maximum of 100 (worst QoL), scored by every domain and by their global score. Scores of independent subscale (Symptom Severity Scale) was calculated in the same way.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 15 Years to 30 Years (Child, Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | Women have a predisposition to stress urinary incontinence, caused by high-impact exercises |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Elite female athletes
- Nulliparous
- Volleyball team.
Exclusion Criteria:
- Inability to contract the PFM, elderly
- Prolapse of the pelvic organs.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03938779
| Contact: Telma F Pires, MSc | +351 936 972 003 | telmafilipapires@gmail.com | |
| Contact: UTAD UTAD | +351 259 350 000 |
| Portugal | |
| Telma Filipa Rodrigues Pereira Pires | Recruiting |
| Vila Real, Trás-os-Montes E Alto Douro, Portugal, 5000-438 | |
| Contact: Telma Pires, MSc (+351) 936 972 003 telmafilipapires@gmail.com | |
| Contact: UTAD (+351) 259 350 000 | |
| Sub-Investigator: Patrícia Pires, MSc | |
| Sub-Investigator: Helena Moreira, Dr | |
| Sub-Investigator: Paulo Vicente, Dr | |
| Sub-Investigator: Sara Viana, Dr | |
| Sub-Investigator: Rui Viana, Dr | |
| Responsible Party: | Telma Pires, principal investigator, University of Trás-os-Montes and Alto Douro |
| ClinicalTrials.gov Identifier: | NCT03938779 |
| Other Study ID Numbers: |
25/2017 |
| First Posted: | May 6, 2019 Key Record Dates |
| Last Update Posted: | July 8, 2019 |
| Last Verified: | July 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | Urinary incontinence is a public health problem, which we must combat intervention measures and publication of clinical trials to prevent and treat urinary incontinence. The PFMT is the first line treatment advised by recent literature. |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Elite Athletes Volleyball Pelvic Floor Muscle Training |
|
Urinary Incontinence Enuresis Urinary Incontinence, Stress Pelvic Floor Disorders Urination Disorders Urologic Diseases |
Lower Urinary Tract Symptoms Urological Manifestations Behavioral Symptoms Elimination Disorders Mental Disorders Pregnancy Complications |

